The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis

被引:139
|
作者
Mueller, Borna [1 ,2 ]
Borrell, Sonia [1 ,2 ]
Rose, Graham [3 ]
Gagneux, Sebastien [1 ,2 ]
机构
[1] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland
[2] Univ Basel, Basel, Switzerland
[3] Natl Inst Med Res, MRC, Div Mycobacterial Res, London NW7 1AA, England
基金
瑞士国家科学基金会; 美国国家卫生研究院;
关键词
drug resistance; persistence; hypermutation; compensatory mutations; epistasis; DRUG-RESISTANCE; ANTIBIOTIC-RESISTANCE; PSEUDOMONAS-AERUGINOSA; POPULATION-GENETICS; BEIJING GENOTYPE; SOUTH-AFRICA; MUTATIONS; FITNESS; COST; EPISTASIS;
D O I
10.1016/j.tig.2012.11.005
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Recent surveillance data of multidrug-resistant tuberculosis (MDR-TB) reported the highest rates of resistance ever documented. As further amplification of resistance in MDR strains of Mycobacterium tuberculosis occurs, extensively drug-resistant (XDR) and totally drug-resistant (TDR) TB are beginning to emerge. Although for the most part, the epidemiological factors involved in the spread of MDR-TB are understood, insights into the bacterial drivers of MDR-TB have been gained only recently, largely owing to novel technologies and research in other organisms. Herein, we review recent findings on how bacterial factors, such as persistence, hypermutation, the complex interrelation between drug resistance and fitness, compensatory evolution, and epistasis affect the evolution of multidrug resistance in M. tuberculosis. Improved knowledge of these factors will help better predict the future trajectory of MDR-TB, and contribute to the development of new tools and strategies to combat this growing public health threat.
引用
收藏
页码:160 / 169
页数:10
相关论文
共 50 条
  • [1] Peritoneal tuberculosis due to multidrug-resistant Mycobacterium tuberculosis
    Esposito, Susanna
    Bosis, Samantha
    Canazza, Lorena
    Tenconi, Rossana
    Torricelli, Maurizio
    Principi, Nicola
    PEDIATRICS INTERNATIONAL, 2013, 55 (02) : E20 - E22
  • [2] Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis
    Turett, GS
    Fazal, BA
    Justman, JE
    Alland, D
    Duncalf, RM
    Telzak, EE
    CLINICAL INFECTIOUS DISEASES, 1997, 24 (03) : 513 - 514
  • [3] Multidrug-resistant Mycobacterium tuberculosis: Molecular perspectives
    Rattan, A
    Kalia, A
    Ahmad, N
    EMERGING INFECTIOUS DISEASES, 1998, 4 (02) : 195 - 209
  • [4] Multidrug-Resistant Mycobacterium tuberculosis, Southwestern Colombia
    Ferro, Beatriz E.
    Nieto, Luisa Maria
    Rozo, Juan C.
    Forero, Liana
    van Soolingen, Dick
    EMERGING INFECTIOUS DISEASES, 2011, 17 (07) : 1259 - 1262
  • [5] VIRULENCE OF MULTIDRUG-RESISTANT MYCOBACTERIUM-TUBERCULOSIS
    ZYKOV, MP
    ROULET, H
    GAYA, N
    POTI, SJ
    EXPERIMENTELLE PATHOLOGIE, 1973, 8 (02): : 73 - 97
  • [6] The pncA gene mutations of Mycobacterium tuberculosis in multidrug-resistant tuberculosis
    Mahmood, Nasir
    Bhatti, Sadia
    Abbas, Shahzada Nadeem
    Shahid, Saman
    Nasir, Sarah Bushra
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2022, 69 (05) : 2195 - 2204
  • [7] Double infection with a resistant and a multidrug-resistant strain of Mycobacterium tuberculosis
    Niemann, S
    Richter, E
    Rüsch-Gerdes, S
    Schlaak, M
    Greinert, U
    EMERGING INFECTIOUS DISEASES, 2000, 6 (05) : 548 - 551
  • [8] NOSOCOMIAL TRANSMISSION OF MULTIDRUG-RESISTANT MYCOBACTERIUM-TUBERCULOSIS
    JARVIS, WR
    RESEARCH IN MICROBIOLOGY, 1993, 144 (02) : 117 - 122
  • [9] Clusters of Multidrug-Resistant Mycobacterium tuberculosis Cases, Europe
    Devaux, Isabelle
    Kremer, Kristin
    Heersma, Herre
    Van Socilingen, Dick
    EMERGING INFECTIOUS DISEASES, 2009, 15 (07) : 1052 - 1060
  • [10] Multidrug-resistant Mycobacterium tuberculosis transmission in Shandong, China
    Li, Yingying
    Li, Yifan
    Wang, Tingting
    Li, Yameng
    Tao, Ningning
    Kong, Xianglong
    Zhang, Yuzhen
    Han, Qilin
    Liu, Yao
    Li, Huaichen
    MEDICINE, 2024, 103 (12) : E37617